Keyphrases
Early-stage Lung Cancer
100%
Angiogenic Factors
100%
Cytokine Factors
100%
Tumor Shrinkage
100%
Factor Screening
100%
Pazopanib
100%
Plasma Cytokines
100%
Soluble Vascular Endothelial Growth Factor receptor-2
50%
Interleukin-12 (IL-12)
33%
Clinical Trials
16%
Tumor Volume
16%
T Cells
16%
Interleukin-4 (IL-4)
16%
Chemokines
16%
Predictive Biomarker
16%
Factor Level
16%
Unmet Needs
16%
Plasma Samples
16%
Stromal Cell-derived factor-1 (SDF-1)
16%
Antiangiogenic Agents
16%
Pathway Inhibitors
16%
Platelet-derived Growth Factor Receptor (PDGFR)
16%
Phase II Trial
16%
Monokines
16%
Tumor Response
16%
Placental Growth Factor (PlGF)
16%
Vascular Endothelial Growth Factor Receptor (VEGFR)
16%
Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)
16%
IP-10
16%
C-kit
16%
VEGF Pathway
16%
Multiplex Assay
16%
Hepatocyte Growth Factor
16%
Soluble Factors
16%
Last Days
16%
Angiogenesis Inhibitors
16%
Pharmacodynamic Biomarker
16%
Days of Therapy
16%
Post-treatment Changes
16%
Multiplex ELISA
16%
Multivariate Classification
16%
Medicine and Dentistry
Non Small Cell Lung Cancer
100%
Neoplasm
100%
Cytokine
100%
Angiogenic Factor
100%
Pazopanib
100%
Vasculotropin Receptor 2
50%
Interleukin 12
33%
Vasculotropin
33%
Angiogenesis Inhibitor
33%
Clinical Trial
16%
Interleukin 4
16%
Arm
16%
Biological Marker
16%
Stromal Cell Derived Factor 1
16%
Factor XII
16%
Pharmacodynamics
16%
Platelet Derived Growth Factor Receptor
16%
Enzyme Linked Immunosorbent Assay
16%
Phase II Trials
16%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
16%
Placental Growth Factor
16%
Scatter Factor
16%
Monokine
16%
Cutaneous T Cell Attracting Chemokine
16%
Oral
16%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Cytokine
100%
Angiogenic Factor
100%
Non Small Cell Lung Cancer
100%
Pazopanib
100%
Vasculotropin Receptor 2
50%
Interleukin 12
33%
Vasculotropin
33%
Angiogenesis Inhibitor
33%
Biological Marker
16%
Interleukin 4
16%
Clinical Trial
16%
Stromal Cell Derived Factor 1
16%
Pharmacodynamics
16%
Enzyme-Linked Immunosorbent Assay
16%
Phase II Trials
16%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
16%
Blood Clotting Factor 12
16%
Monokine
16%
Placental Growth Factor
16%
Scatter Factor
16%
Platelet Derived Growth Factor Receptor
16%
Cutaneous T Cell Attracting Chemokine
16%
Biochemistry, Genetics and Molecular Biology
Cytokine
100%
Blood Plasma
100%
Pazopanib
100%
Kinase Insert Domain Receptor
50%
Interleukin 12
33%
Vascular Endothelial Growth Factor
33%
Clinical Trial
16%
T Cell
16%
Chemokine
16%
Tumor Necrosis Factor
16%
Angiogenesis
16%
Tumor Volume
16%
Interleukin 4
16%
Platelet-Derived Growth Factor Receptor
16%
Stromal Cell-Derived Factor 1
16%
Placental Growth Factor
16%
Factor XII
16%
Pharmacodynamics
16%
Phase II Trials
16%
Hepatocyte Growth Factor
16%
Monokine
16%
Programmed Cell Death
16%